Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue

Molecular and Cellular Endocrinology

Volumn 188, Issue 1-2, 2002, Pages 125-140

  Fasco, Michael J ^a,b   Hurteau, Gregory J ^a   Spivack, Simon D ^a,b,c  

^a Molec Genetic Epidemiol Laboratory   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Alternatively spliced estrogen receptor mRNAs; Estrogen receptor mRNA analysis; Estrogen receptor transcriptional regulation; Gender; Lung cancer

Indexed keywords

COTININE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; NICOTINE;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; BRONCHUS TUMOR; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; FEMALE; GENDER; GENE EXPRESSION; GENE PROBE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MALE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SEX DIFFERENCE; SMOKING;

EID: 0037169815     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(01)00750-X     Document Type: Article

References (52)

1. Women and lung cancer: Waiting to exhale
2. Estrogen and progesterone receptors in bronchogenic carcinoma
3. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line
4. Dissociation between steroid receptor expression and cell proliferation in the human breast
5. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse
6. The determination of nicotine and cotinine in plasma
7. Presence of exon 5-deleted oestrogen receptor in human breast cancer: Functional analysis and clinical significance
8. Prognosis of patients with lung cancer diagnosed in Norway, 1954-93
9. The epidemiology of lung cancer in women
10. Quantitation of estrogen receptor mRNA and its alternatively spliced mRNAs in breast tumor cells and tissues
11. Estrogen receptor mRNA splice variants produced from the distal and proximal promoter transcripts
12. Quantitative RNA-polymerase chain reaction-DNA analysis by capillary electrophoresis and laser-induced fluorescence
13. Expression of an estrogen receptor alpha variant protein in cell lines and tumors
14. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors
15. Cigarettes, sex, and lung adenocarcinoma
16. The oestrogen receptors (ERα and ERβ) and their role in breast cancer: A review
17. Estrogen receptor beta in the breast: Role in estrogen responsiveness and development of breast cancer
18. Race and sex differences in lung cancer risk associated with cigarette smoking
19. Two promoters in expression of estrogen receptor messenger RNA in human breast cancer
20. Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure
21. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer
22. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
23. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
24. Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis
25. 4-Hydroxylation of estrogens as marker of human mammary tumors
26. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: Implications for the mechanism of uterine tumorigenesis
27. Estrogen receptor-beta mRNA variants in human and murine tissues
28. Lung cancer in women: Sex-associated differences in survival of patients undergoing resection for lung cancer
29. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients
30. Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection
31. Molecular cloning and characterization of human estrogen receptor betacx: A potential inhibitor of estrogen action in humans
32. The estrogen receptor variant lacking exon 5 has dominant negative activity in the human breast epithelial cell line HMT-3522S1
33. Lung cancer in women: The importance of smoking, family history of cancer, and medical history of respiratory disease
34. Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild-type estrogen receptor in ovarian carcinomas
35. Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma
36. Expression of estrogen receptor-beta protein and mRNA in the cerebellum of the rat
37. Molecular and genetic aspects of lung cancer
38. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients
39. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1
40. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors
41. Role of estrogens in non-small cell lung cancer
42. Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR
43. Coexpression of estrogen receptor alpha and beta: Poor prognostic factors in human breast cancer?
44. CYP1B1 expression in human lung
45. Expression of estrogen and progesterone receptors in non-small-cell lung cancer: Immunohistochemical study
46. Re: Endocrine factors and adenocarcinoma of the lung in women
47. Immunolocalisation of oestrogen receptor beta in human tissues
48. Cigarette smoking and changes in the histopathology of lung cancer
49. Risk factors for malignant diseases - A cohort study on a population of 22,946 icelanders
50. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines
51. Differences in lung cancer risk between men and women: Examination of the evidence